|
|
Volumn 12, Issue 9, 2001, Pages 1219-1220
|
|
ESMO recommendations for the application of haematopoietic growth factors (hGFs)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
GRANULOCYTE COLONY STIMULATING FACTOR;
GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;
HEMOPOIETIC GROWTH FACTOR;
ACUTE GRANULOCYTIC LEUKEMIA;
ACUTE LEUKEMIA;
ACUTE LYMPHOBLASTIC LEUKEMIA;
ARTICLE;
AUTOLOGOUS BONE MARROW TRANSPLANTATION;
BODY TEMPERATURE DISORDER;
CONTROLLED STUDY;
DEATH;
DISEASE SEVERITY;
FEBRILE NEUTROPENIA;
GRAFT FAILURE;
HUMAN;
INCIDENCE;
INFECTION;
LEUKOCYTE COUNT;
LEUKOPENIA;
MORTALITY;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
PROPHYLAXIS;
RADIOTHERAPY;
RISK ASSESSMENT;
STEM CELL TRANSPLANTATION;
THROMBOCYTOPENIA;
TREATMENT CONTRAINDICATION;
TREATMENT INDICATION;
WORLD HEALTH ORGANIZATION;
ANTINEOPLASTIC AGENTS;
BONE MARROW TRANSPLANTATION;
FEVER;
GRAFT REJECTION;
GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR;
HEMATOPOIETIC STEM CELL MOBILIZATION;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMANS;
LEUKEMIA;
NEOPLASMS;
NEUTROPENIA;
PRACTICE GUIDELINES;
RISK ASSESSMENT;
|
|
EID: 0034778021
PISSN: 09237534
EISSN: None
Source Type: Journal
DOI: 10.1023/A:1012468723966 Document Type: Article |
|
Times cited : (10)
|
|
References (3)
|
